Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| 1 |
Broadcom
AVGO
|
+$784M |
| 2 |
Amgen
AMGN
|
+$695M |
| 3 |
Eli Lilly
LLY
|
+$512M |
| 4 |
Apple
AAPL
|
+$485M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$471M |
Top Sells
| 1 |
Adobe
ADBE
|
+$935M |
| 2 |
NVIDIA
NVDA
|
+$837M |
| 3 |
TJX Companies
TJX
|
+$533M |
| 4 |
CTLT
CATALENT, INC.
CTLT
|
+$364M |
| 5 |
Starbucks
SBUX
|
+$357M |
Sector Composition
| 1 | Technology | 35.94% |
| 2 | Healthcare | 18.89% |
| 3 | Consumer Discretionary | 9.38% |
| 4 | Financials | 9.11% |
| 5 | Industrials | 8.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
326
Axon Enterprise
AXON
$57.5B
| $64.8M | 0.03% |
220,343
-213,284
| -49% | -$62.8M |
|
327
Roper Technologies
ROP
$55.9B
| $64.6M | 0.03% |
114,569
-2,953
| -3% | -$1.67M |
|
|
WIRE
328
DELISTED
Encore Wire Corp
WIRE
| $64.5M | 0.03% |
222,671
-934
| -0.4% | -$271K |
|
329
Vanguard FTSE Emerging Markets ETF
VWO
$98.5B
| $63.8M | 0.03% |
+1,459,032
| New | +$63.8M |
|
330
Inspire Medical Systems
INSP
$2.41B
| $63.6M | 0.03% |
475,235
+461,635
| +3,394% | +$61.8M |
|
331
HDFC Bank
HDB
$179B
| $63.5M | 0.03% |
987,467
-36,447
| -4% | -$2.35M |
|
332
Piper Sandler
PIPR
$5.91B
| $63.2M | 0.03% |
274,772
-25,747
| -9% | -$5.93M |
|
333
Commercial Metals
CMC
$6.54B
| $63.1M | 0.03% |
1,147,404
-12,365
| -1% | -$680K |
|
334
DexCom
DXCM
$30.7B
| $63.1M | 0.03% |
556,150
-3,368
| -0.6% | -$382K |
|
335
Churchill Downs
CHDN
$6.85B
| $63M | 0.03% |
451,156
+18,289
| +4% | +$2.55M |
|
336
Rocket Pharmaceuticals
RCKT
$346M
| $62.8M | 0.03% |
2,919,078
+313,062
| +12% | +$6.74M |
|
337
LiveRamp
RAMP
$1.79B
| $62.6M | 0.03% |
2,024,649
-226,445
| -10% | -$7.01M |
|
338
First Industrial Realty Trust
FR
$6.79B
| $62M | 0.03% |
1,304,909
+1,240,517
| +1,927% | +$58.9M |
|
339
Insight Enterprises
NSIT
$3.99B
| $61.5M | 0.03% |
310,096
-46,334
| -13% | -$9.19M |
|
340
Descartes Systems
DSGX
$9.19B
| $61.4M | 0.03% |
633,522
-55,244
| -8% | -$5.35M |
|
341
Fabrinet
FN
$13.2B
| $60.9M | 0.03% |
248,844
-27,510
| -10% | -$6.73M |
|
342
Hillenbrand
HI
$1.76B
| $60.8M | 0.03% |
1,520,089
-286,513
| -16% | -$11.5M |
|
343
Alnylam Pharmaceuticals
ALNY
$63.2B
| $60.6M | 0.03% |
249,440
+70,486
| +39% | +$17.1M |
|
344
Merus
MRUS
$5.18B
| $60.2M | 0.03% |
1,017,007
+474,427
| +87% | +$28.1M |
|
345
UBS Group
UBS
$127B
| $59.7M | 0.03% |
2,029,403
-1,218,086
| -38% | -$35.9M |
|
346
Fulton Financial
FULT
$3.5B
| $59.7M | 0.03% |
3,518,400
+586,599
| +20% | +$9.96M |
|
347
Exxon Mobil
XOM
$472B
| $58.9M | 0.03% |
511,721
-211,926
| -29% | -$24.4M |
|
348
Entegris
ENTG
$12.3B
| $58.5M | 0.03% |
431,985
-60
| -0% | -$8.12K |
|
349
Tandem Diabetes Care
TNDM
$849M
| $58.4M | 0.03% |
1,450,175
-750,622
| -34% | -$30.2M |
|
350
Mine Safety
MSA
$6.61B
| $58.3M | 0.03% |
310,742
-1,480
| -0.5% | -$278K |
|